Filing Flows › Johnson & Johnson (JNJ) › Who owns the stock
Who owns Johnson & Johnson (JNJ) stock
4,539 funds reported Johnson & Johnson (JNJ) shares in their latest 13F filings, worth $479.0B in all. The largest holder is BlackRock ($53.9B). Last quarter 2,028 funds added to their stakes and 1818 cut them. Members of Congress and other officials disclosed 21 trades (7 buys, 14 sales).
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 212,098,264 | $53.9B | decrease | 2026-06-30 |
| Vanguard Group | 240,349,660 | $49.7B | increase | 2025-12-31 |
| Vanguard Capital Management LLC | 157,226,374 | $39.9B | increase | 2026-06-30 |
| State Street | 133,776,025 | $34.0B | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 64,370,816 | $16.3B | increase | 2026-06-30 |
| Geode Capital Management, LLC | 59,086,417 | $15.0B | decrease | 2026-06-30 |
| Morgan Stanley | 44,808,254 | $11.4B | increase | 2026-06-30 |
| State Farm Mutual Automobile Insurance | 31,590,952 | $8.0B | unchanged | 2026-06-30 |
| Northern Trust | 28,792,064 | $7.3B | decrease | 2026-06-30 |
| Bank of America | 23,438,141 | $6.0B | decrease | 2026-06-30 |
| Price T Rowe Associates | 22,996,878 | $5.8B | increase | 2026-06-30 |
| FMR LLC | 22,595,566 | $5.7B | decrease | 2026-06-30 |
| Wellington Management Group LLP | 22,588,696 | $5.7B | increase | 2026-06-30 |
| Bank of New York Mellon | 21,683,347 | $5.5B | decrease | 2026-06-30 |
| Goldman Sachs Group | 19,722,544 | $5.0B | increase | 2026-06-30 |
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2026-09-30 | Thomas H. Kean Jr | partial sale | $1K–$15K |
| 2026-09-08 | Lloyd Doggett | purchase | $1K–$15K |
| 2026-08-27 | Thomas H. Kean Jr | partial sale | $1K–$15K |
| 2026-08-20 | John Boozman | partial sale | $1K–$15K |
| 2026-07-30 | Richard Dean Dr McCormick | sale | $1K–$15K |
| 2026-06-29 | Thomas H. Kean Jr | partial sale | $1K–$15K |
| 2026-06-09 | Lloyd Doggett | purchase | $1K–$15K |
| 2026-06-02 | Thomas H. Kean Jr | partial sale | $1K–$15K |
| 2026-03-30 | Alan Armstrong | purchase | $1K–$15K |
| 2026-03-27 | Alan Armstrong | purchase | $15K–$50K |
Johnson & Johnson's latest quarter
Johnson & Johnson, Q3 2026: revenue $25.4B (+6% year over year), operating margin 0.1%, net earnings $210M, operating cash flow $7.7B. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most JNJ stock?
By the latest 13F filings: BlackRock ($53.9B); Vanguard Group ($49.7B); Vanguard Capital Management LLC ($39.9B); State Street ($34.0B); Vanguard Portfolio Management LLC ($16.3B).
Has Congress traded JNJ stock?
Officials disclosed 21 trades on file: 7 buys and 14 sales. The latest: Thomas H. Kean Jr, partial sale on 2026-09-30.
What is the short interest in JNJ?
16,766,729 shares were sold short at the 2026-10-15 settlement, -24.03% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.